Stay updated on Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Sign up to get notified when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.

Latest updates to the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about KZR-616 for polymyositis and dermatomyositis, and the revision number has been updated from v2.14.3 to v2.15.0.SummaryDifference21%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.6%
- Check52 days agoChange DetectedDifference0.5%
- Check67 days agoChange DetectedDifference0.3%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.